Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:816389rdf:typepubmed:Citationlld:pubmed
pubmed-article:816389lifeskim:mentionsumls-concept:C0030909lld:lifeskim
pubmed-article:816389lifeskim:mentionsumls-concept:C1881708lld:lifeskim
pubmed-article:816389lifeskim:mentionsumls-concept:C0332472lld:lifeskim
pubmed-article:816389lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:816389lifeskim:mentionsumls-concept:C2702333lld:lifeskim
pubmed-article:816389lifeskim:mentionsumls-concept:C1547179lld:lifeskim
pubmed-article:816389pubmed:issue10lld:pubmed
pubmed-article:816389pubmed:dateCreated1976-7-6lld:pubmed
pubmed-article:816389pubmed:abstractTextThe rate of pepsin hydrolysis of the four subclasses of human IgG has been studied. The levels of undegraded IgG and of pep-F'c fragments have been determined by radial immunodiffusion using specific antisera against Cgamma2 and Cgamma3 domain antigenic determinants. This study shows that the four IgG subclasses have different susceptibilities to pepsin hydrolysis and defines the optimum conditions (times of hydrolysis) for the preparation of maximum yields of F (ab)'2 fragments and/or pep-F'c fragments.lld:pubmed
pubmed-article:816389pubmed:languagefrelld:pubmed
pubmed-article:816389pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:816389pubmed:citationSubsetIMlld:pubmed
pubmed-article:816389pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:816389pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:816389pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:816389pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:816389pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:816389pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:816389pubmed:statusMEDLINElld:pubmed
pubmed-article:816389pubmed:issn0300-9084lld:pubmed
pubmed-article:816389pubmed:authorpubmed-author:RopartzCClld:pubmed
pubmed-article:816389pubmed:authorpubmed-author:RivatCClld:pubmed
pubmed-article:816389pubmed:issnTypePrintlld:pubmed
pubmed-article:816389pubmed:volume57lld:pubmed
pubmed-article:816389pubmed:ownerNLMlld:pubmed
pubmed-article:816389pubmed:authorsCompleteYlld:pubmed
pubmed-article:816389pubmed:pagination1209-13lld:pubmed
pubmed-article:816389pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:816389pubmed:meshHeadingpubmed-meshheading:816389-H...lld:pubmed
pubmed-article:816389pubmed:meshHeadingpubmed-meshheading:816389-P...lld:pubmed
pubmed-article:816389pubmed:meshHeadingpubmed-meshheading:816389-P...lld:pubmed
pubmed-article:816389pubmed:meshHeadingpubmed-meshheading:816389-K...lld:pubmed
pubmed-article:816389pubmed:meshHeadingpubmed-meshheading:816389-I...lld:pubmed
pubmed-article:816389pubmed:meshHeadingpubmed-meshheading:816389-I...lld:pubmed
pubmed-article:816389pubmed:meshHeadingpubmed-meshheading:816389-I...lld:pubmed
pubmed-article:816389pubmed:meshHeadingpubmed-meshheading:816389-M...lld:pubmed
pubmed-article:816389pubmed:meshHeadingpubmed-meshheading:816389-I...lld:pubmed
pubmed-article:816389pubmed:year1975lld:pubmed
pubmed-article:816389pubmed:articleTitle[Kinetic study of human immunoglobulin G fragmentation by pepsin].lld:pubmed
pubmed-article:816389pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:816389pubmed:publicationTypeEnglish Abstractlld:pubmed